Advertisement

Ads Placeholder
Loading...

LifeMD, Inc.

LFMDNASDAQ
Healthcare
Medical - Pharmaceuticals
$3.51
$-0.07(-1.96%)
U.S. Market opens in 5h 42m

LifeMD, Inc. (LFMD) Stock Overview

Explore LifeMD, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap168.4M
P/E Ratio-27.39
EPS (TTM)$-0.30
ROE-1.18%
Fundamental Analysis

AI Price Forecasts

1 Month$3.25
3 Months$7.11
1 Year Target$5.95

LFMD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of LifeMD, Inc. (LFMD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 45.92, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $5.95.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -27.39 and a market capitalization of 168.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.96%
5-Day Change
-9.54%
1-Month Change
20.62%
3-Month Change
0.57%
6-Month Change
-49.64%
Year-to-Date (YTD) Change
0.57%
1-Year Change
-34.02%
3-Year Change
106.47%
5-Year Change
-79.69%
All-Time (Max) Change
1655.00%

Contact Information

866 351 5907
236 Fifth Avenue, New York City, NY, 10001

Company Facts

3,040 Employees
IPO DateJan 29, 2008
CountryUS
Actively Trading

Frequently Asked Questions